Aurobindo Pharma Shares Decline 2.01% in Today's Trading Session
With the stock currently trading at Rs 1141.50, Aurobindo Pharma has experienced a notable decline in today's session.
Alpha Desk
May 12, 2025 / 09:49 IST
DisclaimerThis is an AI-assisted live blog with updates sourced from multiple news outlets and agenciesDisclaimer
During today's trading session, Aurobindo Pharma shares experienced a decline of 2.01%, with the current price at Rs 1141.50. This movement positions Aurobindo Pharma among the top losers within the NIFTY MIDCAP 150 index. The stock's performance reflects a notable shift in investor sentiment during the trading day.
Financial Performance Overview
Aurobindo Pharma's recent financial performance offers key insights into its market standing. The following sections summarize the company's consolidated quarterly and annual results, providing a detailed perspective on its financial health.
Quarterly Performance Analysis
Aurobindo Pharma's consolidated quarterly performance reveals the following:
December 2024: Revenue reached Rs 7,978.52 Cr, an increase compared to Rs 7,351.78 Cr in December 2023.
Net Profit: The company reported a net profit of Rs 843.98 Cr for December 2024, a slight decrease from Rs 942.56 Cr in the same period last year.
Earnings Per Share (EPS): EPS stood at Rs 14.56 in December 2024, down from Rs 16.04 in December 2023.
Annual Performance Analysis
An overview of Aurobindo Pharma's consolidated annual performance highlights these trends:
Revenue: Increased from Rs 23,098.51 Cr in 2020 to Rs 29,001.87 Cr in 2024.
Net Profit: Rose from Rs 2,844.69 Cr to Rs 3,186.13 Cr during the same period.
Earnings Per Share (EPS): Increased from Rs 48.32 in 2020 to Rs 54.16 in 2024.
Key Financial Ratios (Mar 2024)
The key financial ratios as of March 2024 provide additional context to the company's financial stability:
Book Value per Share: Rs 509.49
Return on Equity: 10.63%
Debt to Equity Ratio: 0.21
Market Positioning and Sentiment
Aurobindo Pharma's inclusion in the NIFTY MIDCAP 150 index underscores its importance within the mid-cap segment of the Indian stock market. According to Moneycontrol's sentiment analysis on May 6, 2025, the outlook for the stock was bullish. With the stock currently trading at Rs 1141.50, Aurobindo Pharma has experienced a notable decline in today's session.
